DEFA14A: Select Medical Holdings Corporation Announces 2025 Annual Stockholder Meeting

Select Medical Holdings Corporation will hold its annual stockholder meeting virtually on April 24, 2025, to vote on key proposals including director elections and executive compensation.

Summary

• Select Medical Holdings Corporation is holding its 2025 Annual Meeting of Stockholders on April 24, 2025, at 11:00am Eastern Time, virtually.
• Stockholders will vote on several proposals, including the election of four Class I directors for three-year terms.
• A proposal to amend the company's certificate of incorporation to eliminate supermajority voting requirements will be voted on.
• Stockholders will also vote to approve the company's Non-Employee Director Compensation Policy.
• A stockholder proposal to amend the certificate of incorporation to elect each director annually will be considered.
• A non-binding advisory vote on the compensation of named executive officers will take place.
• The appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025, will be ratified.
• The Board of Directors recommends voting FOR the director nominees and Proposals 2, 3, 5, and 6, and makes NO RECOMMENDATION on Proposal 4.
• Stockholders can access proxy materials and vote online or request a paper copy.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. The board's recommendations provide some positive direction for investors.

Positives

• The company is providing multiple avenues for stockholders to access proxy materials and vote, including online, phone, and email.
• The board is providing clear recommendations on how to vote on each proposal, except for Proposal 4.

Future Outlook

The document outlines the agenda for the upcoming annual meeting and provides recommendations on voting for the listed proposals.

Management Comments

• The Board of Directors recommends a vote FOR each Board of Directors nominee, FOR Proposals 2, 3, 5 and 6, and NO RECOMMENDATION on Proposal 4.

Industry Context

This is a standard proxy statement related to an upcoming annual meeting, which is a routine part of corporate governance for publicly traded companies.

Stakeholder Impact

• Shareholders will be able to vote on key decisions affecting the company's governance and direction.
• The outcome of the votes will influence the composition of the board and the company's policies.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• Attend the virtual Annual Meeting on April 24, 2025.

Key Dates

Keywords

Annual Meeting, Stockholders, Proxy Statement, Director Election, Executive Compensation, Select Medical Holdings, Voting, PricewaterhouseCoopers